Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VNRX-7145 and ceftibuten drug-drug interaction, safety, and pharmacokinetic study in healthy adults
NL-OMON51149Active, not recruiting
- Sponsor
- Venatorx Pharmaceuticals
- Start
- May 2021
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of ledaborbactam etzadroxil and ceftibuten in bacterial disease (7 arms), sponsored by Venatorx Pharmaceuticals. Started May 2021; status: active, not recruiting.
02
Drugs
ledaborbactam etzadroxilceftibuten
03
Conditions
bacterial disease
Beyond the preview
Go deeper on NL-OMON51149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51149.